THOC5_HUMAN - dbPTM
THOC5_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID THOC5_HUMAN
UniProt AC Q13769
Protein Name THO complex subunit 5 homolog
Gene Name THOC5
Organism Homo sapiens (Human).
Sequence Length 683
Subcellular Localization Nucleus . Cytoplasm . Shuttles between nucleus and cytoplasm.
Protein Description Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. THOC5 in conjunction with ALYREF/THOC4 functions in NXF1-NXT1 mediated nuclear export of HSP70 mRNA; both proteins enhance the RNA binding activity of NXF1 and are required for NXF1 localization to the nuclear rim. Involved in transcription elongation and genome stability. Involved in alternative polyadenylation site choice by recruiting CPSF6 to 5' region of target genes; probably mediates association of the TREX and CFIm complexes.; Regulates the expression of myeloid transcription factors CEBPA, CEBPB and GAB2 by enhancing the levels of phosphatidylinositol 3,4,5-trisphosphate. May be involved in the differentiation of granulocytes and adipocytes. Essential for hematopoietic primitive cell survival and plays an integral role in monocytic development..
Protein Sequence MSSESSKKRKPKVIRSDGAPAEGKRNRSDTEQEGKYYSEEAEVDLRDPGRDYELYKYTCQELQRLMAEIQDLKSRGGKDVAIEIEERRIQSCVHFMTLKKLNRLAHIRLKKGRDQTHEAKQKVDAYHLQLQNLLYEVMHLQKEITKCLEFKSKHEEIDLVSLEEFYKEAPPDISKAEVTMGDPHQQTLARLDWELEQRKRLAEKYRECLSNKEKILKEIEVKKEYLSSLQPRLNSIMQASLPVQEYLFMPFDQAHKQYETARHLPPPLYVLFVQATAYGQACDKTLSVAIEGSVDEAKALFKPPEDSQDDESDSDAEEEQTTKRRRPTLGVQLDDKRKEMLKRHPLSVMLDLKCKDDSVLHLTFYYLMNLNIMTVKAKVTTAMELITPISAGDLLSPDSVLSCLYPGDHGKKTPNPANQYQFDKVGILTLSDYVLELGHPYLWVQKLGGLHFPKEQPQQTVIADHSLSASHMETTMKLLKTRVQSRLALHKQFASLEHGIVPVTSDCQYLFPAKVVSRLVKWVTVAHEDYMELHFTKDIVDAGLAGDTNLYYMALIERGTAKLQAAVVLNPGYSSIPPVFQLCLNWKGEKTNSNDDNIRAMEGEVNVCYKELCGPWPSHQLLTNQLQRLCVLLDVYLETESHDDSVEGPKEFPQEKMCLRLFRGPSRMKPFKYNHPQGFFSHR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSSESSKKR
------CCCCHHHCC
42.6920068231
2Acetylation------MSSESSKKR
------CCCCHHHCC
42.6922814378
2O-linked_Glycosylation------MSSESSKKR
------CCCCHHHCC
42.6930379171
3Phosphorylation-----MSSESSKKRK
-----CCCCHHHCCC
39.9520068231
5Phosphorylation---MSSESSKKRKPK
---CCCCHHHCCCCC
49.7815221008
6Phosphorylation--MSSESSKKRKPKV
--CCCCHHHCCCCCE
37.8415221008
16PhosphorylationRKPKVIRSDGAPAEG
CCCCEECCCCCCCCC
29.3120068231
24AcetylationDGAPAEGKRNRSDTE
CCCCCCCCCCCCCCH
37.7023954790
28PhosphorylationAEGKRNRSDTEQEGK
CCCCCCCCCCHHCCC
53.0528176443
30PhosphorylationGKRNRSDTEQEGKYY
CCCCCCCCHHCCCEE
40.5930576142
37PhosphorylationTEQEGKYYSEEAEVD
CHHCCCEECCCEEEC
17.06-
56UbiquitinationGRDYELYKYTCQELQ
CCCHHHHHHHHHHHH
46.86-
66SulfoxidationCQELQRLMAEIQDLK
HHHHHHHHHHHHHHH
3.2421406390
732-HydroxyisobutyrylationMAEIQDLKSRGGKDV
HHHHHHHHHCCCCCE
46.53-
74O-linked_GlycosylationAEIQDLKSRGGKDVA
HHHHHHHHCCCCCEE
43.3830379171
78AcetylationDLKSRGGKDVAIEIE
HHHHCCCCCEEEEEH
52.4326051181
146UbiquitinationHLQKEITKCLEFKSK
HHHHHHHHHHHHHHC
42.35-
153SumoylationKCLEFKSKHEEIDLV
HHHHHHHCCCCCCEE
56.4728112733
175UbiquitinationEAPPDISKAEVTMGD
HCCCCCCCCEECCCC
49.23-
180SulfoxidationISKAEVTMGDPHQQT
CCCCEECCCCHHHHH
7.4721406390
204AcetylationQRKRLAEKYRECLSN
HHHHHHHHHHHHHHC
43.9626051181
210PhosphorylationEKYRECLSNKEKILK
HHHHHHHHCHHHHHH
58.47-
212AcetylationYRECLSNKEKILKEI
HHHHHHCHHHHHHHH
57.9426051181
2172-HydroxyisobutyrylationSNKEKILKEIEVKKE
HCHHHHHHHHHHHHH
61.18-
217AcetylationSNKEKILKEIEVKKE
HCHHHHHHHHHHHHH
61.1826051181
217UbiquitinationSNKEKILKEIEVKKE
HCHHHHHHHHHHHHH
61.18-
222UbiquitinationILKEIEVKKEYLSSL
HHHHHHHHHHHHHHC
27.39-
2232-HydroxyisobutyrylationLKEIEVKKEYLSSLQ
HHHHHHHHHHHHHCH
57.69-
223UbiquitinationLKEIEVKKEYLSSLQ
HHHHHHHHHHHHHCH
57.69-
225PhosphorylationEIEVKKEYLSSLQPR
HHHHHHHHHHHCHHH
22.2918373705
293PhosphorylationLSVAIEGSVDEAKAL
EEEEEECCHHHHHHH
17.38-
307PhosphorylationLFKPPEDSQDDESDS
HCCCCCCCCCCCCCC
33.5726846344
312PhosphorylationEDSQDDESDSDAEEE
CCCCCCCCCCHHHHH
49.7826846344
314PhosphorylationSQDDESDSDAEEEQT
CCCCCCCCHHHHHHH
48.2626846344
321PhosphorylationSDAEEEQTTKRRRPT
CHHHHHHHHHHCCCC
37.2523927012
322PhosphorylationDAEEEQTTKRRRPTL
HHHHHHHHHHCCCCC
23.4223927012
328PhosphorylationTTKRRRPTLGVQLDD
HHHHCCCCCCCCCCH
34.0429255136
336UbiquitinationLGVQLDDKRKEMLKR
CCCCCCHHHHHHHHH
66.10-
347PhosphorylationMLKRHPLSVMLDLKC
HHHHCCCEEEEEEEE
15.2120068231
412UbiquitinationYPGDHGKKTPNPANQ
CCCCCCCCCCCCCCC
74.03-
420PhosphorylationTPNPANQYQFDKVGI
CCCCCCCCCCCCEEE
15.79-
477UbiquitinationSHMETTMKLLKTRVQ
HHHHHHHHHHHHHHH
48.88-
477AcetylationSHMETTMKLLKTRVQ
HHHHHHHHHHHHHHH
48.8825953088
491AcetylationQSRLALHKQFASLEH
HHHHHHHHHHHCCCC
48.2226051181
514UbiquitinationCQYLFPAKVVSRLVK
CCEECCHHHHHHHHH
43.33-
517PhosphorylationLFPAKVVSRLVKWVT
ECCHHHHHHHHHHHH
23.9227174698
524PhosphorylationSRLVKWVTVAHEDYM
HHHHHHHHHCCHHHH
15.7427174698
530PhosphorylationVTVAHEDYMELHFTK
HHHCCHHHHHHEECC
6.9027174698
536PhosphorylationDYMELHFTKDIVDAG
HHHHHEECCCCHHCC
19.6327174698
610AcetylationGEVNVCYKELCGPWP
CCEEEEHHHHHCCCC
38.8026051181

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
5SPhosphorylationKinasePRKCAP17252
GPS
6SPhosphorylationKinasePRKCAP17252
GPS
225YPhosphorylationKinasePDGFRBP09619
PSP
225YPhosphorylationKinaseSRCP12931
Uniprot
307SPhosphorylationKinaseATMQ13315
PSP
312SPhosphorylationKinaseATMQ13315
PSP
314SPhosphorylationKinaseATMQ13315
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
5SPhosphorylation

23032722
6SPhosphorylation

23032722
328TPhosphorylation

20068231

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of THOC5_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DX39B_HUMANDDX39Bphysical
15998806
THOC2_HUMANTHOC2physical
15998806
THOC1_HUMANTHOC1physical
15998806
THOC3_HUMANTHOC3physical
15998806
THOC6_HUMANTHOC6physical
15998806
THOC7_HUMANTHOC7physical
15998806
THOC4_HUMANALYREFphysical
15998806
SMAD4_HUMANSMAD4physical
17190602
NCBP1_HUMANNCBP1physical
17190602
THOC4_HUMANALYREFphysical
17190602
DX39B_HUMANDDX39Bphysical
17190602
THOC2_HUMANTHOC2physical
17190602
THOC7_HUMANTHOC7physical
22939629
THOC6_HUMANTHOC6physical
22939629
ZC3HF_HUMANZC3H15physical
22939629
XPO4_HUMANXPO4physical
22939629
ZKSC5_HUMANZKSCAN5physical
22939629
VIME_HUMANVIMphysical
22939629
U3IP2_HUMANRRP9physical
22939629
UTRO_HUMANUTRNphysical
22939629
ZPR1_HUMANZPR1physical
22939629
ZN606_HUMANZNF606physical
22939629
ZO2_HUMANTJP2physical
22939629
UBR7_HUMANUBR7physical
22939629
LSM3_HUMANLSM3physical
22365833
PPIL1_HUMANPPIL1physical
22365833
THOC1_HUMANTHOC1physical
22365833
ZN830_HUMANZNF830physical
22365833
THOC2_HUMANTHOC2physical
26344197
THOC3_HUMANTHOC3physical
26344197
THOC6_HUMANTHOC6physical
26344197
THOC7_HUMANTHOC7physical
26344197
ZO1_HUMANTJP1physical
26344197
FMNL1_HUMANFMNL1physical
26496610
T2FA_HUMANGTF2F1physical
26496610
PGFRA_HUMANPDGFRAphysical
26496610
RL6_HUMANRPL6physical
26496610
RL22_HUMANRPL22physical
26496610
RL27A_HUMANRPL27Aphysical
26496610
DX39B_HUMANDDX39Bphysical
26496610
IF4A3_HUMANEIF4A3physical
26496610
ZC11A_HUMANZC3H11Aphysical
26496610
THOC1_HUMANTHOC1physical
26496610
THOC4_HUMANALYREFphysical
26496610
DX39A_HUMANDDX39Aphysical
26496610
KIF1C_HUMANKIF1Cphysical
26496610
RT27_HUMANMRPS27physical
26496610
SIR1_HUMANSIRT1physical
26496610
CCDC9_HUMANCCDC9physical
26496610
CHTOP_HUMANCHTOPphysical
26496610
WDR74_HUMANWDR74physical
26496610
MGN2_HUMANMAGOHBphysical
26496610
NCBP3_HUMANC17orf85physical
26496610
DDX24_HUMANDDX24physical
26496610
THOC2_HUMANTHOC2physical
26496610
K1522_HUMANKIAA1522physical
26496610
MYO1G_HUMANMYO1Gphysical
26496610
THOC6_HUMANTHOC6physical
26496610
ZC3HE_HUMANZC3H14physical
26496610
THOC7_HUMANTHOC7physical
26496610
KLF16_HUMANKLF16physical
26496610
UIF_HUMANFYTTD1physical
26496610
PDIP3_HUMANPOLDIP3physical
26496610
THOC3_HUMANTHOC3physical
26496610
SPB12_HUMANSERPINB12physical
26496610
IMP4_HUMANIMP4physical
26496610
CS047_HUMANC19orf47physical
26496610

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of THOC5_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-312 ANDSER-314, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312 AND SER-314, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-312 ANDSER-314, AND MASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-312 ANDSER-314, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312 AND SER-314, ANDMASS SPECTROMETRY.
"THOC5 spliceosome protein: a target for leukaemogenic tyrosinekinases that affects inositol lipid turnover.";
Pierce A., Carney L., Hamza H.G., Griffiths J.R., Zhang L.,Whetton B.A., Gonzalez Sanchez M.B., Tamura T., Sternberg D.,Whetton A.D.;
Br. J. Haematol. 141:641-650(2008).
Cited for: MASS SPECTROMETRY, AND PHOSPHORYLATION AT TYR-225.

TOP